A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development
about
A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trialH5N1 vaccines in humansA single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferretsA single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocol.Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen.An inactivated, adjuvanted whole virion clade 2.2 H5N1 (A/Chicken/Astana/6/05) influenza vaccine is safe and immunogenic in a single dose in humans.Protection of Chinese painted quails (Coturnix chinensis) against a highly pathogenic H5N1 avian influenza virus strain after vaccination.Dose sparing and the lack of a dose-response relationship with an influenza vaccine in adult and elderly patients - a randomized, double-blind clinical trial.An examination of the predictors of blood donors' intentions to donate during two phases of an avian influenza outbreak.Aluminum salts as an adjuvant for pre-pandemic influenza vaccines: a meta-analysis
P2860
Q24623902-525E4FDE-FF67-4A45-9FE6-F219FBA51978Q27000896-B90A189A-81FF-41B5-804B-72C3E810512FQ30389924-7F9AA7A5-F86D-4CED-9A85-EB76F677A5F7Q30392828-17D97DC9-FBF5-4152-A5B5-426BA168D28AQ30399951-D9BD57AB-24E1-48C2-97F1-BDCE49461EE6Q33741316-DE172AC6-A4E6-4A01-B3C7-235B9F77F7ECQ37124744-955CF80E-789A-45D3-AEC0-7BAEADCF147CQ37316060-EF3EFAFC-FEFB-4758-9A16-C680E224EFE1Q38853908-CFC84949-D254-4913-B754-983CB15B4138Q43953556-2EC98AD5-019B-4291-8F9B-5A0A3092FEF6Q57094173-C65DF98B-B773-47C0-9E6E-B98C4B448F4D
P2860
A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A single-dose influenza A (H5N ...... o pandemic vaccine development
@ast
A single-dose influenza A (H5N ...... o pandemic vaccine development
@en
A single-dose influenza A (H5N ...... o pandemic vaccine development
@nl
type
label
A single-dose influenza A (H5N ...... o pandemic vaccine development
@ast
A single-dose influenza A (H5N ...... o pandemic vaccine development
@en
A single-dose influenza A (H5N ...... o pandemic vaccine development
@nl
prefLabel
A single-dose influenza A (H5N ...... o pandemic vaccine development
@ast
A single-dose influenza A (H5N ...... o pandemic vaccine development
@en
A single-dose influenza A (H5N ...... o pandemic vaccine development
@nl
P2093
P2860
P356
P1433
P1476
A single-dose influenza A (H5N ...... o pandemic vaccine development
@en
P2093
Gyorgy Paragh
Ildiko Visontay
Istvan Jankovics
Istvan Szilvasy
Kálmán Bartha
Lajos Kosa
Zoltan Vajo
Zsuzsanna Pauliny
P2860
P304
P356
10.1128/JVI.01894-09
P407
P577
2010-02-01T00:00:00Z